We used quantitative immunohistochemistry [8] to show that the expression of BTF3, HINT1, NDRG1 and ODC1 proteins is increased in prostate cancer tissue and could serve as putative targets for the investigation of carcinogenesis or biomarkers for disease. The gene discussed is BTF3; the disease is prostate cancer.